HomeHPX • FRA
add
Hisamitsu Pharmaceutical Co Inc
Nakaraang pagsara
€25.60
Sakop ng araw
€25.80 - €25.80
Sakop ng taon
€21.00 - €28.80
Market cap
364.25B JPY
Average na Volume
6.00
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(JPY) | Ago 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 39.65B | 13.66% |
Gastos sa pagpapatakbo | 18.75B | 17.95% |
Net na kita | 4.31B | -1.33% |
Net profit margin | 10.87 | -13.18% |
Kita sa bawat share | — | — |
EBITDA | 6.35B | 20.49% |
Aktuwal na % ng binabayarang buwis | 28.38% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(JPY) | Ago 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 122.74B | -13.22% |
Kabuuang asset | 350.48B | 1.79% |
Kabuuang sagutin | 74.55B | 7.74% |
Kabuuang equity | 275.92B | — |
Natitirang share | 73.34M | — |
Presyo para makapag-book | 0.01 | — |
Return on assets | 3.52% | — |
Return on capital | 4.46% | — |
Cash Flow
Net change in cash
(JPY) | Ago 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 4.31B | -1.33% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
The Hisamitsu Pharmaceutical Co., Inc., headquartered in Saga and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch. Hisamitsu has specialised in transdermal drug delivery system technology since the introduction of its original line of patches in 1903.
Hisamitsu's products under the Salonpas and Bye-Bye Fever brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the U.S Food and Drug Administration. Wikipedia
Itinatag
1847
Headquarters
Website
Mga Empleyado
2,759